GSK-2018682

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGSK-2018682
Drug Alias NameGSK-20186822018682
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor agonists
TargetsSphingosine 1-phosphate receptor
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A